Dyne Therapeutics
50 hedge funds and large institutions have $554M invested in Dyne Therapeutics in 2020 Q3 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
60.52% more ownership
Funds ownership: 0% → 60.52% (+61%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$109M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$65.1M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$61.6M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$55.8M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$38.4M |
Top Sellers
DYN Hedge Fund Activity: Q3 2020 in Review
50 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q3 2020, worth a combined $554M.
Buyers outnumbered sellers: 50 funds opened new DYN positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was MPM Asset Management, opening a new position worth an estimated $109M.
- 50 institutional investors held Dyne Therapeutics (DYN) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $554M of Dyne Therapeutics stock for Q3 2020.
- 50 funds opened new Dyne Therapeutics positions in Q3 2020 and 0 closed out, a net change of +50 holders.
- The largest Dyne Therapeutics buyer in Q3 2020 was MPM Asset Management, an estimated $109M added.
Based on aggregated 13F filings for Q3 2020.